Castle Biosciences(CSTL) - 2024 Q1 - Quarterly Report

During the three months ended March 31, 2024, there were no significant changes to the information discussed under "Critical Accounting Estimates" included in the Management's Discussion and Analysis of Financial Condition and Results of Operations section of our Annual Report on Form 10-K for the year ended December 31, 2023. Item 3. Quantitative and Qualitative Disclosures About Market Risk. Table of Contents Our exposure to inflationary pressures is primarily in personnel and related costs. The extent of ...